Antibody-based diagnostic and therapeutic innovations for human cancer.
As adjuvants, antibody-based diagnostic and therapeutic innovations can potentially decrease morbidity and mortality associated with many human malignancies. Current strategies employing genetically modified constructs may improve tumor penetration and increase versatility.
Kramer
K
K
Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Cheung
N K
NK
D000911:Antibodies, Monoclonal / Q000235:genetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D014481:United States
D000911:Antibodies, Monoclonal; D019275:Radiopharmaceuticals